查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2127589

2026年全球核糖核酸（RNA）原位雜合反應（ISH）市場報告

Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，核糖核酸（RNA）原位雜合反應（ISH）市場發展迅速。預計該市場將從2025年的14.9億美元成長到2026年的16.6億美元，複合年成長率（CAGR）為11.1%。這一成長主要歸功於癌症生物標記研究的進展、學術界對分子生物學投入的增加、螢光顯微鏡技術的日益普及、感染疾病診斷的日益廣泛以及早期核酸檢測方法的開發。

預計未來幾年，核糖核酸（RNA）原位雜合反應（ISH）市場將快速成長。預計到2030年，該市場將以10.7%的複合年成長率成長，達到24.9億美元。預測期內的成長主要歸因於精準腫瘤診斷需求的不斷成長、空間轉錄組學技術的廣泛應用、個人化醫療的更廣泛應用、檢查室工作流程自動化的進步以及對先進基因組研究基礎設施投資的增加。預測期內的關鍵趨勢包括：利用人工智慧驅動的空間轉錄組學影像分析來提高RNA訊號解讀的準確性；開發能夠同時檢測多個目標RNA的超靈敏多重探針；開發能夠減少人為誤差並提高處理能力的自動化玻片雜合反應平台；開發能夠實現高解析度細胞內RNA成像的先進基因螢光系統；以及單細胞表達譜分析的創新，以加深對組織水平的理解。

感染疾病檢測數量的不斷成長預計將推動核糖核酸（RNA）原位雜合反應（ISH）市場的發展。感染疾病檢測是指透過分子和實驗室分析，利用診斷方法來辨識病毒、細菌和其他病原體引起的感染。感染疾病檢測數量的成長得益於先進分子診斷技術的日益普及，這些技術能夠更快、更準確地識別病原體。 RNA原位雜合反應（ISH）透過識別和定位組織檢體中病原體特異性RNA，提高了感染疾病檢測的準確性，從而能夠在保持組織形態的同時，準確地觀察受感染細胞。例如，根據英國衛生安全局2026年5月的數據，2026年1月1日至5月25日期間，英國共報告了630例實驗室確診的麻疹病例，比2026年5月11日發布的上一份報告增加了88例。因此，感染疾病檢測數量的增加正在推動核糖核酸（RNA）原位雜合反應（ISH）市場的成長。

精準醫療的日益普及預計將進一步加速核糖核酸（RNA）原位雜合反應（ISH）市場的成長。精準醫療是一種基於個人基因譜、生物標記和分子特徵，實現疾病預防、診斷和治療個人化的醫療方法。慢性疾病（尤其是癌症）的日益流行，需要高度標靶和個人化的治療策略，這推動了精準醫療的普及。 RNA原位雜合反應（ISH）透過檢測和定位組織樣本中的特定RNA生物標記物，為精準醫療提供支持，從而促進分子譜分析，指南標靶治療，並有助於改善患者治療效果，實現最佳治療效果。例如，2024 年 2 月，總部位於美國的醫院和醫療機構協會——個人化醫療聯盟報告稱，FDA 在 2023 年批准了 16 種針對罕見疾病患者的新型個人化療法，比 2022 年的 6 種有所增加。因此，精準醫療的日益普及正在推動核糖核酸 (RNA) 原位雜合反應(ISH) 市場的成長。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球核糖核酸（RNA）原位雜合反應（ISH）市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 人工智慧驅動的空間轉錄組影像分析提高了RNA訊號解讀的準確性。
    • 開發能夠同時偵測多個目標RNA的超靈敏多重探針。
    • 一種自動化玻片雜合反應平台，可減少人為錯誤並提高處理能力。
    • 一種先進的螢光成像系統，可實現高解析度的細胞內RNA成像。
    • 單細胞表現譜分析技術的創新加深了我們對組織層級基因表現的理解。

第5章 終端用戶產業市場分析

  • 學術研究機構
  • 製藥和生物技術公司
  • 臨床實驗室
  • 醫院和診斷中心
  • 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球核糖核酸（RNA）原位雜合反應（ISH）市場：PESTEL分析
  • 全球核糖核酸（RNA）原位雜合反應（ISH）市場：規模、比較和成長率分析
  • 全球核糖核酸（RNA）原位雜合反應（ISH）市場表現：規模與成長，2020-2025年
  • 全球核糖核酸（RNA）原位雜合反應（ISH）市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 探針、試劑盒及試劑、儀器、服務
  • 透過技術
  • 螢光原位雜合反應、顯色原位雜合反應、核糖核酸範圍
  • 透過使用
  • 診斷應用、癌症研究、感染疾病、神經科學、發育生物學、基因表現研究。
  • 最終用戶
  • 學術和研究機構、製藥和生物技術公司、臨床檢測實驗室
  • 按類型進行細分：探針
  • 單分子探針、螢光標記探針、顯色探針、地高辛標記探針、生物素標記探針、鎖核酸探針、核糖核酸探針、去氧核糖核酸探針、多重探針、客製化探針
  • 按類型細分：試劑盒和試劑
  • 檢測試劑盒、擴增試劑盒、雜合反應緩衝液、洗滌緩衝液、訊號檢測試劑、封閉試劑、複染試劑、探針標記試劑、封片劑、樣本製備試劑
  • 按類型細分：設備
  • 自動化雜合反應系統、玻片處理系統、數位影像系統、螢光顯微鏡、明場顯微鏡、切片機、組織處理設備、玻片掃描器、 聚合酵素連鎖反應熱迴圈儀、實驗室自動化系統
  • 按類型細分：服務
  • 客製化檢測開發服務、樣品檢測服務、合約研究服務、探針設計服務、數據分析服務、實驗室驗證服務、技術支援服務、培訓服務、諮詢服務、維修服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 核糖核酸（RNA）原位雜合反應（ISH）市場：競爭模式與市場佔有率，2024年
  • 核糖核酸（RNA）原位雜合反應（ISH）市場：公司估值矩陣
  • 核糖核酸（RNA）原位雜合反應（ISH）市場：公司概況
    • Roche Diagnostics International AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies Inc.

第37章 其他大型企業和創新企業

  • Charles River Laboratories, QIAGEN NV, Bio-Techne Corporation, Akoya Biosciences Inc., Biocare Medical LLC, Biogenex Laboratories Inc., Empire Genomics LLC, BioChain Institute Inc., Boster Biological Technology Co. Ltd., AnaPath Services GmbH, Bio SB Inc., Enzo Biochem Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年核糖核酸（RNA）原位雜合反應（ISH）市場：提供新機會的國家
  • 2030 年核糖核酸 (RNA) 原位雜合反應(ISH) 市場：提供新機會的細分市場
  • 2030年核糖核酸（RNA）原位雜合反應（ISH）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: PH6MRSHI01_G26Q3

A ribonucleic acid (RNA) in situ hybridization (ISH) is a molecular method used to detect and visualize specific RNA sequences within cells or tissue samples. It allows researchers and clinicians to determine the localization and expression patterns of target RNA molecules while maintaining the structural integrity of the sample. A ribonucleic acid (RNA) in situ hybridization (ISH) uses labeled complementary probes that attach to specific RNA targets for microscopic detection and analysis.

The primary product types of ribonucleic acid (RNA) in situ hybridization (ISH) include probes, kits and reagents, instruments, and services. Probes refer to labeled nucleic acid sequences developed to identify and bind with specific RNA targets within cells or tissue samples. These products utilize technologies such as fluorescence in situ hybridization, chromogenic in situ hybridization, and ribonucleic acid scope. The major applications include diagnostic applications, cancer research, infectious diseases, neuroscience, developmental biology, and gene expression studies, while the end-users comprise academic and research institutes, pharmaceutical and biotechnology companies, and clinical laboratories.

Tariffs are influencing the ribonucleic acid (RNA) in situ hybridization (ISH) market by increasing the cost of imported probes, imaging systems, and specialized reagents used in molecular diagnostics and research workflows. This is extending procurement timelines and increasing operational expenses across product segments such as probes, kits and reagents, instruments, and automated hybridization systems, particularly in regions such as Asia-Pacific and Europe that depend heavily on imported laboratory technologies. Diagnostic laboratories and academic research institutes are also experiencing delayed access to advanced imaging and sequencing-compatible tools due to ongoing global supply chain disruptions. However, tariffs are encouraging localized manufacturing, regional supplier diversification, and greater investment in domestic biotechnology ecosystems, which may enhance long-term supply resilience and innovation capacity.

The ribonucleic acid (rna) in situ hybridization (ish) market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) in situ hybridization (ish) market statistics, including ribonucleic acid (rna) in situ hybridization (ish) industry global market size, regional shares, competitors with a ribonucleic acid (rna) in situ hybridization (ish) market share, detailed ribonucleic acid (rna) in situ hybridization (ish) market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) in situ hybridization (ish) industry. This ribonucleic acid (rna) in situ hybridization (ish) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (RNA) in situ hybridization (ish) market size has grown rapidly in recent years. It will grow from $1.49 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growth in cancer biomarker research, expansion of academic molecular biology funding, increasing adoption of fluorescence microscopy techniques, rising prevalence of infectious disease diagnostics, development of early nucleic acid detection methods.

The ribonucleic acid (RNA) in situ hybridization (ish) market size is expected to see rapid growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising demand for precision oncology diagnostics, increasing adoption of spatial transcriptomics technologies, expansion of personalized medicine applications, growth in automated laboratory workflows, increasing investment in advanced genomic research infrastructure. Major trends in the forecast period include AI assisted spatial transcriptomics image analysis improving rna signal interpretation accuracy, ultra sensitive multiplex probe development enabling simultaneous multi target rna detection, automated slide hybridization platforms reducing manual error and improving throughput, advanced fluorescent imaging systems enabling high resolution intracellular rna mapping, single cell expression profiling innovations enhancing tissue level gene expression insights.

The rising infectious disease detection is expected to propel the growth of the ribonucleic acid (RNA) in situ hybridization (ISH) market going forward. Infectious disease detection refers to the growing application of diagnostic methods to identify viral, bacterial, and other pathogenic infections through molecular and laboratory-based analyses. The increase in infectious disease detection is driven by the expanding adoption of advanced molecular diagnostic technologies that provide faster and more accurate pathogen identification. RNA in situ hybridization (ISH) enhances infectious disease detection by identifying and localizing pathogen-specific RNA within tissue specimens, enabling precise visualization of infected cells while preserving tissue morphology. For instance, in May 2026, according to the UK Health Security Agency, a UK-based government agency, between 1 January and 25 May 2026, England reported 630 laboratory-confirmed measles cases, marking an increase of 88 cases compared with the previous report published on 11 May 2026. Therefore, the rising infectious disease detection is driving the growth of the ribonucleic acid (RNA) in situ hybridization (ISH) market.

The increasing adoption of precision medicine is expected to propel the growth of the ribonucleic acid (RNA) in situ hybridization (ISH) market going forward. Precision medicine is a healthcare approach that tailors disease prevention, diagnosis, and treatment based on an individual's genetic profile, biomarkers, and molecular characteristics. The adoption of precision medicine is rising due to the increasing prevalence of chronic diseases, particularly cancer, which require highly targeted and personalized treatment strategies. RNA in situ hybridization (ISH) supports precision medicine by detecting and localizing specific RNA biomarkers within tissue samples, facilitating molecular profiling that guides targeted therapies and enhances patient-specific treatment outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six in 2022. Therefore, the increasing adoption of precision medicine is driving the growth of the ribonucleic acid (RNA) in situ hybridization (ISH) market.

Major companies operating in the ribonucleic acid (RNA) in situ hybridization (ISH) market are prioritizing strategic partnerships to advance workflow automation, enhance RNA biomarker visualization, improve diagnostic accuracy, and support high-throughput molecular pathology analysis. Strategic partnerships are collaborative agreements between organizations that combine resources, expertise, or capabilities to achieve common objectives, expand market reach, and foster mutual growth. For instance, in March 2026, Leica Biosystems Nussloch GmbH, a Germany-based medical technology manufacturer, partnered with Bio-Techne Corporation, a US-based life sciences company, to introduce BOND-PRIME RNAscope Brown Detection, designed to enhance automated chromogenic RNA in situ hybridization workflows, improve RNA biomarker visualization, and support high-throughput digital pathology and molecular diagnostics applications. Its key distinguishing feature is the fully automated integration of the RNAscope in situ hybridization (ISH) workflow with the BOND-PRIME Staining Platform, enabling faster, standardized RNA biomarker detection while minimizing manual intervention.

Major companies operating in the ribonucleic acid (RNA) in situ hybridization (ish) market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Charles River Laboratories, QIAGEN N.V., Bio-Techne Corporation, Akoya Biosciences Inc., Biocare Medical LLC, Biogenex Laboratories Inc., Empire Genomics LLC, BioChain Institute Inc., Boster Biological Technology Co. Ltd., AnaPath Services GmbH, Bio SB Inc., Enzo Biochem Inc.

North America was the dominating region in the ribonucleic acid (RNA) in situ hybridization (ISH) market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) in situ hybridization (ISH) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) in situ hybridization (ISH) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) in situ hybridization (ISH) market consists of revenues earned by entities by providing services such as biomarker identification, molecular pathology testing, and tissue-based diagnostic research. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) in situ hybridization (ISH) market also includes sales of assay controls, detection substrates, hybridization buffers, target-specific RNA probes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ribonucleic acid (rna) in situ hybridization (ish) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) in situ hybridization (ish) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) in situ hybridization (ish) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Probes; Kits And Reagents; Instruments; Services
  • 2) By Technology: Fluorescence In Situ Hybridization; Chromogenic In Situ Hybridization; Ribonucleic Acid Scope
  • 3) By Application: Diagnostic Applications; Cancer Research; Infectious Diseases; Neuroscience; Developmental Biology; Gene Expression Studies
  • 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories
  • Subsegments:
  • 1) By Probes: Single Molecule Probes; Fluorescently Labeled Probes; Chromogenic Probes; Digoxigenin Labeled Probes; Biotin Labeled Probes; Locked Nucleic Acid Probes; Ribonucleic Acid Probes; Deoxyribonucleic Acid Probes; Multiplex Probes; Custom Designed Probes
  • 2) By Kits And Reagents: Detection Kits; Amplification Kits; Hybridization Buffers; Wash Buffers; Signal Detection Reagents; Blocking Reagents; Counterstain Reagents; Probe Labeling Reagents; Mounting Media Reagents; Sample Preparation Reagents
  • 3) By Instruments: Automated Hybridization Systems; Slide Processing Systems; Digital Imaging Systems; Fluorescence Microscopes; Brightfield Microscopes; Microtome Instruments; Tissue Processing Instruments; Slide Scanners; Thermal Cycler Instruments; Laboratory Automation Systems
  • 4) By Services: Custom Assay Development Services; Sample Testing Services; Contract Research Services; Probe Design Services; Data Analysis Services; Laboratory Validation Services; Technical Support Services; Training Services; Consulting Services; Maintenance Services
  • Companies Mentioned: Roche Diagnostics International AG; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Agilent Technologies Inc.; Charles River Laboratories; QIAGEN N.V.; Bio-Techne Corporation; Akoya Biosciences Inc.; Biocare Medical LLC; Biogenex Laboratories Inc.; Empire Genomics LLC; BioChain Institute Inc.; Boster Biological Technology Co. Ltd.; AnaPath Services GmbH; Bio SB Inc.; Enzo Biochem Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 AI Assisted Spatial Transcriptomics Image Analysis Improving RNA Signal Interpretation Accuracy
    • 4.2.2 Ultra Sensitive Multiplex Probe Development Enabling Simultaneous Multi Target RNA Detection
    • 4.2.3 Automated Slide Hybridization Platforms Reducing Manual Error And Improving Throughput
    • 4.2.4 Advanced Fluorescent Imaging Systems Enabling High Resolution Intracellular RNA Mapping
    • 4.2.5 Single Cell Expression Profiling Innovations Enhancing Tissue Level Gene Expression Insights

5. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Analysis Of End Use Industries

  • 5.1 Academic And Research Institutes
  • 5.2 Pharmaceutical And Biotechnology Companies
  • 5.3 Clinical Laboratories
  • 5.4 Hospitals And Diagnostic Centers
  • 5.5 Other End Users

6. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Segmentation

  • 9.1. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Probes, Kits And Reagents, Instruments, Services
  • 9.2. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence In Situ Hybridization, Chromogenic In Situ Hybridization, Ribonucleic Acid Scope
  • 9.3. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Applications, Cancer Research, Infectious Diseases, Neuroscience, Developmental Biology, Gene Expression Studies
  • 9.4. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories
  • 9.5. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Molecule Probes, Fluorescently Labeled Probes, Chromogenic Probes, Digoxigenin Labeled Probes, Biotin Labeled Probes, Locked Nucleic Acid Probes, Ribonucleic Acid Probes, Deoxyribonucleic Acid Probes, Multiplex Probes, Custom Designed Probes
  • 9.6. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Detection Kits, Amplification Kits, Hybridization Buffers, Wash Buffers, Signal Detection Reagents, Blocking Reagents, Counterstain Reagents, Probe Labeling Reagents, Mounting Media Reagents, Sample Preparation Reagents
  • 9.7. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Hybridization Systems, Slide Processing Systems, Digital Imaging Systems, Fluorescence Microscopes, Brightfield Microscopes, Microtome Instruments, Tissue Processing Instruments, Slide Scanners, Thermal Cycler Instruments, Laboratory Automation Systems
  • 9.8. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Custom Assay Development Services, Sample Testing Services, Contract Research Services, Probe Design Services, Data Analysis Services, Laboratory Validation Services, Technical Support Services, Training Services, Consulting Services, Maintenance Services

10. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Regional And Country Analysis

  • 10.1. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 11.1. Asia-Pacific Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 12.1. China Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 13.1. India Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 14.1. Japan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 15.1. Australia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 16.1. Indonesia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 17.1. South Korea Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 18.1. Taiwan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 19.1. South East Asia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 20.1. Western Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 21.1. UK Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 22.1. Germany Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 23.1. France Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 24.1. Italy Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 25.1. Spain Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 26.1. Eastern Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 27.1. Russia Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 28.1. North America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 29.1. USA Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 30.1. Canada Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 31.1. South America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 32.1. Brazil Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 33.1. Middle East Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

  • 34.1. Africa Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Regulatory and Investment Landscape

36. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Competitive Landscape And Company Profiles

  • 36.1. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Company Profiles
    • 36.3.1. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Other Major And Innovative Companies

  • Charles River Laboratories, QIAGEN N.V., Bio-Techne Corporation, Akoya Biosciences Inc., Biocare Medical LLC, Biogenex Laboratories Inc., Empire Genomics LLC, BioChain Institute Inc., Boster Biological Technology Co. Ltd., AnaPath Services GmbH, Bio SB Inc., Enzo Biochem Inc.

38. Global Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market

41. Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market High Potential Countries, Segments and Strategies

  • 41.1 Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Ribonucleic Acid (RNA) In Situ Hybridization (ISH) Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer